Japanese Patent Office upholds key Charpentier-Doudna CRISPR patent
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, issued a statement saying that the Japanese Patent Office (JPO) has rejected arguments filed in opposition to the second Japanese patent (JP6692856) filed by Dr. Charpentier, together with The Regents of the University of […]